Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Skjalg Bruheim

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Investigational New Drugs|January 13, 2010
Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor modelsAndries M Bergman, Auke D Adema, Jan Balzarini, et al.
The EMBO Journal|June 18, 2005
VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesisTaro Matsumoto, Svante Bohman, Johan Dixelius, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Investigational New Drugs|January 13, 2010
Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor modelsAndries M Bergman, Auke D Adema, Jan Balzarini, et al.
The EMBO Journal|June 18, 2005
VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesisTaro Matsumoto, Svante Bohman, Johan Dixelius, et al.
Pageof 2